Product Information

CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.7068 per GM under NDC 00378868835. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Aug 11, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN-BENZOYL PEROX 1-5%

clindamycin phosphate and benzoyl peroxide
$0.7068per GM

NDC

00378868835

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA065443

FDA Approved

8/11/2009

TE Code

AB

On Market Since

9/19/2014

Price Statistics

The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 83.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7068 per GM
All-time high$6.7391 (Oct 14, 2015)
All-time low$0.6901 (Jun 17, 2026)
52-week high$0.8776
52-week low$0.6901
Median price$1.9720
Average price$2.7845
Largest weekly change+35.1% (Jan 18, 2023)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-2.8%

1M

-4.8%

3M

-3.9%

6M

+1.6%

1Y

-16.5%

3Y

-28.8%

5Y

-60.5%

All

-83.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 20%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Mylan Pharmaceuticals Inc., is $0.7068 per GM (NDC 00378868835), effective Nov 18, 2026.

How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 83.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.6901 (Jun 17, 2026) to a high of $6.7391 (Oct 14, 2015), with a median of $1.9720 per GM.

Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5646 per GM — about 20% below CLINDAMYCIN-BENZOYL PEROX 1-5%.

Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?

CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 00378868835) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.